(Q24246544)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253475%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

0 references

1 reference

title

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253475%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

0 references

1 reference

M Vardi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253475%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

A Nini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253475%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

24 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253475%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253475%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253475%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

CD002187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253475%20AND%20SRC:MED&resulttype=core&format=json

Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Effects of tadalafil on erectile dysfunction in men with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Sildenafil in the treatment of erectile dysfunction in men with diabetes: demand, efficacy and patient satisfaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Efficacy of sildenafil citrate in treatment of erectile dysfunction: effect of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Sildenafil: efficacy and safety in daily clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Switching from long-term treatment with self-injections to oral sildenafil in diabetic patients with severe erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Nocturnal electrobioimpedance volumetric assessment in diabetic men with erectile dysfunction before and after tadalafil intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Physiology of penile erection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

A Coefficient of Agreement for Nominal Scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

On life satisfaction in male erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Novel phosphodiesterase type 5 inhibitors: assessing hemodynamic effects and safety parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Nitric oxide and cyclic GMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Pharmacotherapeutic advances in the treatment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

Overall cardiovascular profile of sildenafil citrate

21 January 2018

1 reference

12 December 2020

[Sildenafil citrate (viagra) treatment in patients with diabetes mellitus]

1 reference

12 December 2020

Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study

1 reference

12 December 2020

1 reference

12 December 2020

Efficacy and safety of sildenafil in men with type 2 diabetes mellitus and erectile dysfunction

1 reference

12 December 2020

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

Clinical trials of sildenafil citrate (Viagra) demonstrate no increase in risk of myocardial infarction and cardiovascular death compared with placebo

1 reference

12 December 2020

The penis as a vascular organ. The importance of corporal smooth muscle tone in the control of erection

1 reference

12 December 2020

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

1 reference

12 December 2020

Endogenous neurotransmitters mediating penile erection

1 reference

12 December 2020

Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men

1 reference

12 December 2020

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002187.PUB3

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD002187.PUB3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253475%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253475%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference